Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

More Press Releases

Stocks struggle higher as markets remain volatile; oil drops

Dec 10, 2018

NEW YORK — U.S. stocks remained volatile Monday as the market took a dive in early trading only to erase those losses later and end slightly higher. The Dow Jones Industrial Average lost as much as 507 points in early trading before ending with a gain of 34. Energy companies fell as the price of crude oil dropped 3 percent, giving back its gains from last week. Banks fell as investors expected slower increases in interest rates. Technology companies led the gainers. Qualcomm rose after the chipmaker said a Chinese court banned some Apple phones as part of a long-running...

Markets Right Now: US stocks end a bumpy day slightly higher

Dec 10, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Stocks ended another bumpy day slightly higher as gains by big technology companies helped the market erase an early plunge. Facebook added 3.2 percent and Microsoft rose 2.6 percent Monday. Chipmaker Qualcomm rose 2.2 percent after a Chinese court banned some Apple phones as part of a long-running dispute over patents. Energy companies fell as the price of crude oil dropped 3 percent, to give up its gains from last week. Exxon Mobil lost 1.4 percent. The S&P 500 rose 4 points, or 0.2 percent,...

Goodyear halts tire production in Venezuela as economy slips

Dec 10, 2018

VALENCIA, Venezuela — Goodyear Tire & Rubber Co. is halting production in Venezuela, making it the latest international corporation to abandon a South American nation in economic crisis, officials said Monday. Spokesman Eduardo Arguelles told The Associated Press that Goodyear-Venezuela had made the "difficult decision" to no longer produce tires in the country, which has seen an economic contraction worse than the U.S. Great Depression. "Our goal had been to maintain its operations, but economic conditions and U.S. sanctions have made this impossible," Arguelles said. The company had endured tens of millions in losses in recent years as the Venezuelan...

Markets Right Now: Stocks open sharply lower on Wall Street

Dec 10, 2018

NEW YORK — The latest on developments in financial markets (all times local): 9:35 a.m. Stocks are opening sharply lower as the arrest of a senior Chinese technology executive threatened to worsen trade tensions between China and the U.S. The price of oil also fell sharply early Thursday as OPEC leaders gathered to discuss possible cuts in production. The Dow Jones Industrial Average dropped as much as 500 points before erasing some of its losses. Boeing and Caterpillar, which would stand to lose much in an extended trade battle, fell the most in the Dow. Traders continued to shovel money...

Dow slides 700 points as US stocks veer sharply lower

Dec 10, 2018

U.S. stocks veered sharply lower in afternoon trading Tuesday, pulling the Dow Jones Industrial Average down 700 points. The wave of selling erased the market's gains from a day earlier, when stocks rallied on news that the U.S. and China had agreed to a temporary truce in their trade dispute. Investors' confidence in that truce appeared to falter Tuesday, contributing to renewed fears about a slowing global economy. Technology companies, banks and industrial stocks accounted for much of the sell-off as traders moved assets into the relative safety of U.S. government bonds, driving yields sharply lower. Utilities stocks rose. Smaller-company...

Subscribe to our newsletter!

Your Name

Your Email Address